Cecilie Kyrø, Mia K Grand, Janne Bigaard, Maria Rossing, Ann S Knoop, Niels Kroman, Lene Mellemkjær, Christina C Dahm, Pernille E Bidstrup, Anne Tjønneland, Anja Olsen
{"title":"Dietary supplement use and life expectancy after breast cancer - The Danish Diet, Cancer and Health cohort.","authors":"Cecilie Kyrø, Mia K Grand, Janne Bigaard, Maria Rossing, Ann S Knoop, Niels Kroman, Lene Mellemkjær, Christina C Dahm, Pernille E Bidstrup, Anne Tjønneland, Anja Olsen","doi":"10.1016/j.tjnut.2025.09.035","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Dietary supplement use is widespread among women with breast cancer, but evidence regarding the possible health benefits or harms remains limited.</p><p><strong>Objective: </strong>To investigate the association between the use of dietary supplements and life expectancy after breast cancer.</p><p><strong>Methods: </strong>In this prospective cohort study, data from the Danish Diet, Cancer and Health cohort was used. We followed 1,951 incident cases of breast cancer from diagnosis until migration, death, end-of-follow-up or 20 years. Both pre-diagnostic and post-diagnostic dietary supplement use were assessed with an Food Frequency Questionnaire (FFQ), with pre-diagnostic use as main exposure. Dietary supplement use and differences in 20-year life expectancy and life years lost due to breast cancer and other causes, respectively were estimated using pseudo-observations and regression models adjusted for potential confounders.</p><p><strong>Results: </strong>During follow-up (median: 12 years, IQR: 8-17 years), 725 individuals died, with 450 deaths attributed to breast cancer. No association was found for overall dietary supplement use. Multivitamin use indicated an association with longer life expectancy after breast cancer (1.01 years, 95% CI: 0.03, 1.98), primarily due to fewer years lost to breast cancer (-1.06 years, -1.85, -0.27). In exploratory analyses, high supplementary intakes of vitamins A, B12, iron, and magnesium showed tendencies towards poorer life expectancy, while both high and low vitamin D intake were associated with lower life expectancy. Exploratory analyses also suggested that antioxidant supplements may be associated with poorer life expectancy among chemotherapy recipients, but not those receiving radiation therapy.</p><p><strong>Conclusions: </strong>Our results suggest that women with breast cancer may benefit from multivitamin use alone, but should avoid excessive use of dietary supplements-especially antioxidant supplements during chemotherapy and high intakes of certain micronutrients-and should not exceed recommended levels.</p>","PeriodicalId":16620,"journal":{"name":"Journal of Nutrition","volume":" ","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Nutrition","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.tjnut.2025.09.035","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"NUTRITION & DIETETICS","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Dietary supplement use is widespread among women with breast cancer, but evidence regarding the possible health benefits or harms remains limited.
Objective: To investigate the association between the use of dietary supplements and life expectancy after breast cancer.
Methods: In this prospective cohort study, data from the Danish Diet, Cancer and Health cohort was used. We followed 1,951 incident cases of breast cancer from diagnosis until migration, death, end-of-follow-up or 20 years. Both pre-diagnostic and post-diagnostic dietary supplement use were assessed with an Food Frequency Questionnaire (FFQ), with pre-diagnostic use as main exposure. Dietary supplement use and differences in 20-year life expectancy and life years lost due to breast cancer and other causes, respectively were estimated using pseudo-observations and regression models adjusted for potential confounders.
Results: During follow-up (median: 12 years, IQR: 8-17 years), 725 individuals died, with 450 deaths attributed to breast cancer. No association was found for overall dietary supplement use. Multivitamin use indicated an association with longer life expectancy after breast cancer (1.01 years, 95% CI: 0.03, 1.98), primarily due to fewer years lost to breast cancer (-1.06 years, -1.85, -0.27). In exploratory analyses, high supplementary intakes of vitamins A, B12, iron, and magnesium showed tendencies towards poorer life expectancy, while both high and low vitamin D intake were associated with lower life expectancy. Exploratory analyses also suggested that antioxidant supplements may be associated with poorer life expectancy among chemotherapy recipients, but not those receiving radiation therapy.
Conclusions: Our results suggest that women with breast cancer may benefit from multivitamin use alone, but should avoid excessive use of dietary supplements-especially antioxidant supplements during chemotherapy and high intakes of certain micronutrients-and should not exceed recommended levels.
期刊介绍:
The Journal of Nutrition (JN/J Nutr) publishes peer-reviewed original research papers covering all aspects of experimental nutrition in humans and other animal species; special articles such as reviews and biographies of prominent nutrition scientists; and issues, opinions, and commentaries on controversial issues in nutrition. Supplements are frequently published to provide extended discussion of topics of special interest.